Kapadia Sandip
CHIEF FINANCIAL OFFICER at HRMY; Director at PASG; CFO and Treasurer at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $4.2M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jan 26, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- HRMYHarmony Biosciences Holdings, Inc.CHIEF FINANCIAL OFFICER
- PASGPassage BIO, Inc.Director
- INTERCEPT PHARMACEUTICALS INCCFO and Treasurer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- HRMY103,469 shares
- INTERCEPT PHARMACEUTICALS INC5,741 shares
- PASG5,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale HRMYRoutineJan 21 2025
Sold 25,000 shares at $40.18 ($1M)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($1M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale HRMYRoutineJan 27 +6 days
Sold 1,775 shares at $38.05 ($68k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($68k position)0 shares leftFiling
- 3 Form 4 sale HRMYRoutineApr 1 +64 days
Sold 6,987 shares at $32.55 ($227k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($227k position)0 shares leftFiling
- 4 Form 4 sale HRMYUnusualAug 15 +136 days
Sold 21,573 shares at $36.50 ($787k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($787k position)0 shares left3.1x usual sizeFiling
- 5 Form 4 sale HRMYRoutineNov 21 +98 days
Sold 3,427 shares at $35.00 ($120k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($120k position)0 shares left0.2x usual sizeFiling
- 6 Form 4 sale HRMYRoutineDec 5 +14 days
Sold 20,000 shares at $39.54 ($791k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($791k position)0 shares left2.9x usual sizeFiling
- 7 Form 4 sale HRMYRoutineJan 15 +41 days
Sold 20,961 shares at $35.92 ($753k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 100% of holdings ($753k position)0 shares left1.6x usual sizeFiling
- 8 Form 4 sale HRMYRoutineJan 26 +11 days
Sold 3,746 shares at $37.15 ($139k)
Kapadia Sandip, CHIEF FINANCIAL OFFICER
10b5-1 planSold 13.3% of holdings ($1.1M position)24,521 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 3,746 | $139k | 13.3% | Routine | SEC |
| Jan 15, 2026 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 20,961 | $753k | 100.0% | Routine | SEC |
| Dec 5, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 20,000 | $791k | 100.0% | Routine | SEC |
| Nov 21, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 3,427 | $120k | 100.0% | Routine | SEC |
| Aug 15, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 21,573 | $787k | 100.0% | Unusual | SEC |
| Apr 1, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 6,987 | $227k | 100.0% | Routine | SEC |
| Jan 27, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,775 | $68k | 100.0% | Routine | SEC |
| Jan 21, 2025 | HRMY | CHIEF FINANCIAL OFFICER | Form 4 sale | 25,000 | $1M | 100.0% | Routine | SEC |
| Dec 1, 2022 | PASG | Director | Form 4 sale | 5,000 | $6k | 100.0% | Unusual | SEC |
| Jan 5, 2021 | INTERCEPT PHARMACEUTICALS INC | CFO and Treasurer | Form 4 sale | 2,193 | $54k | 8.4% | Plan not stated | SEC |
| Dec 15, 2020 | INTERCEPT PHARMACEUTICALS INC | CFO and Treasurer | Form 4 sale | 1,763 | $58k | 6.1% | Plan not stated | SEC |
| Oct 2, 2017 | INTERCEPT PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 354 | $21k | 1.7% | Plan not stated | SEC |
| Jul 3, 2017 | INTERCEPT PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,431 | $174k | 6.5% | Plan not stated | SEC |